Anti-HDAC8 antibody [EPR10338(2)]
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(1 Review)
|
(46 Publications)
Rabbit Recombinant Monoclonal HDAC8 antibody. Suitable for IP, WB, Flow Cyt (Intra) and reacts with Human, Mouse samples. Cited in 46 publications.
View Alternative Names
HDACL1, CDA07, HDAC8, Histone deacetylase 8, HD8, Protein deacetylase HDAC8, Protein decrotonylase HDAC8
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-HDAC8 antibody [EPR10338(2)] (AB187139)
Intracellular Flow Cytometry analysis of K562 cells labeling HDAC8 using ab187139 at 1/150 dilution. A Goat anti rabbit IgG (FITC) at 1/150 dilution was used as secondary antibody. Cells were fixed with 2% paraformaldehyde. Isotype control : Rabbit monoclonal IgG.
- IP
Supplier Data
Immunoprecipitation - Anti-HDAC8 antibody [EPR10338(2)] (AB187139)
Immunoprecipitation analysis of human fetal kidney tissue lysate labeling HDAC8 using ab187139 at 1/50 dilution (Lane 1). Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1500 was used as secondary antibody. Lane 2 : PBS instead of human fetal kidney tissue lysate.
All lanes:
Immunoprecipitation - Anti-HDAC8 antibody [EPR10338(2)] (ab187139)
Predicted band size: 42 kDa
false
- WB
Supplier Data
Western blot - Anti-HDAC8 antibody [EPR10338(2)] (AB187139)
All lanes:
Western blot - Anti-HDAC8 antibody [EPR10338(2)] (ab187139) at 1/50000 dilution
Lane 1:
K562 cell lysate at 20 µg
Lane 2:
Molt4 cell lysate at 20 µg
Lane 3:
HeLa cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 42 kDa
false
- WB
Lab
Western blot - Anti-HDAC8 antibody [EPR10338(2)] (AB187139)
Western blot : Rabbit Monoclonal [EPR10338(2)] to HDAC8 ab187139 staining at 1/10000 dilution, shown in green; Mouse anti-CANX (ab238078) loading control staining at 1/20,000 dilution, shown in magenta.
A band was observed at 42 kDa in Wild-type U-87 MG cell lysates with no signal observed at this size in HDAC8 knockout U-87 MG cell line.
To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.
Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-HDAC8 antibody [EPR10338(2)] (ab187139) at 1/10000 dilution
Lane 1:
Wild-type U-87 MG at 20 µg
Lane 2:
HDAC8 knockout U-87 MG at 20 µg
Lane 3:
HeLa at 20 µg
Lane 4:
HCT 116 at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 42 kDa
Observed band size: 42 kDa
false
Related conjugates and formulations (2)
-
Anti-HDAC8 antibody [EPR10338(2)] - BSA and Azide free
-
Anti-HDAC8 antibody [EPR10338(2)] - BSA and Azide free (Capture)
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HDAC8 plays a role in regulating transcription by being involved in altering chromatin structure. It does not form part of a large multi-protein complex unlike some other histone deacetylases. Its activity affects cell cycle progression and differentiation which is central to cellular physiology. HDAC8 also participates in non-histone protein deacetylation impacting various substrates allowing it to govern diverse cellular processes.
Pathways
Scientists associate HDAC8 with cell cycle regulation and muscle contraction. HDAC8 plays a role in the molecular pathways that control how myosin light chains undergo deacetylation interacting with proteins such as smooth muscle actin. During cell cycle regulation HDAC8 affects p53 a protein critical in controlling cell cycle progression and apoptosis integrating into pathways that decide cellular outcomes during division and response to stress.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (46)
Recent publications for all applications. Explore the full list and refine your search
Journal of translational medicine 23:1001 PubMed40993625
2025
Applications
Unspecified application
Species
Unspecified reactive species
Mediators of inflammation 2025:8156593 PubMed40151316
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta physiologica (Oxford, England) 240:e14201 PubMed39007513
2024
Applications
Unspecified application
Species
Unspecified reactive species
Non-coding RNA research 9:732-743 PubMed38577018
2024
Applications
Unspecified application
Species
Unspecified reactive species
CNS neuroscience & therapeutics 30:e14573 PubMed38421101
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 43:113575 PubMed38181788
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 84:522-537.e8 PubMed38151017
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell chemical biology 30:1617-1633.e9 PubMed38134881
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 15: PubMed36831463
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 14: PubMed36497494
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com